Company intelligence / Profile preview
Alfa Wassermann
- Ownership
- Private
- Development stage
- Commercial
Overview
Alfa Wassermann has a long-standing presence in the pharmaceutical industry with commercialized products spanning prescription drugs, self-medication specialties, clinical chemistry analyzers for medical/veterinary use, and advanced ultracentrifuge systems used globally by major pharmaceutical companies for vaccine development/manufacturing. The company merged into Alfasigma in the mid-late 2010s but its legacy brands remain active within the group[4][7].
- Therapeutic areas
- OtherInfectious Diseases
- Modalities
- Small molecules (pharmaceuticals)[7]Clinical chemistry systems[3][5]Ultracentrifugation for biologics and vaccines[6][9]
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Alfa Wassermann.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alfa Wassermann.